Can Melatonin Be Used to Treat Macular Degeneration?

November 28, 2010

A recent trial showed that 3mg of melatonin given orally each night at bedtime for 3months to AMD patients reduced pathologic macular changes.

Melatonin is a hormone with antioxidant effects. Researchers hypothesized that melatonin’s antioxidant properties may help stop shortening of telomeres – chromosomal structures that become shorter over time due to factors like aging, inflammation, and damage caused by free radicals). By preventing telomere-shortening in the cells of the retina, the report suggests, melatonin may help preserve eyesight and slow the progression of age-related macular degeneration.

Read a summary of the research for patients here, and an abstract of the research here.




Jump down to form below to submit your own comments

Trackback URL

Have insights to contribute? Please submit your comment below